Titel:
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254 Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Spinner, Christoph D; Felizarta, Franco; Rizzardini, Giuliano; Philibert, Patrick; Mitha, Essack; Domingo, Pere; Stephan, Christoph J; DeGrosky, Michelle; Bainbridge, Veronica; Zhan, Joyce; Dumitrescu, Teodora Pene; Jeffrey, Jerry L; Xu, Jianfeng; Halliday, Fiona; Gan, Jianjun; Johnson, Mark; Gartland, Martin; Joshi, Samit R; Lataillade, Max
Zeitschriftentitel:
Clinical Infectious Diseases
Jahr:
2022
Band / Volume:
75
Heft / Issue:
5
Seitenangaben Beitrag:
786-794
Volltext / DOI:
doi:10.1093/cid/ciab1065 Verlag / Institution:
Oxford University Press (OUP)
E-ISSN:
1058-48381537-6591
Publikationsdatum:
06.01.2022
Login
BibTeX